spar overview

Under the International Health Regulations(IHR) 2005 all States Parties are required to have or develop and maintain minimum core public health capacities to implement the IHR (2005), and report the status of implementation annually, as stipulated in Article 54 of the Regulations.

The formal submission of data from State Parties to the WHO via the IHR annual reports is very important and will be used as the basis for:

JEE

Joint External Evaluation (JEE)

Last updated on 26 May 2025
Completed
In Pipeline
Status Unknown
1% - 20%
21% - 60%
61% - 100%
Region Country JEE Status Start Date End Date Report Custom text
African Region United Republic Of Tanzania Conducted 22-Feb-2016 26-Feb-2016
Eastern Mediterranean Region Pakistan Conducted 26-Apr-2016 06-May-2016
African Region Ethiopia Conducted 29-Feb-2016 04-Mar-2016
African Region Liberia Conducted 05-Sep-2016 09-Sep-2016
African Region Mozambique Conducted 18-Apr-2016 22-Apr-2016
Eastern Mediterranean Region Morocco Conducted 20-Jun-2016 24-Jun-2016
Eastern Mediterranean Region Qatar Conducted 29-May-2016 02-Jun-2016
South-East Asia Region Bangladesh Conducted 08-May-2016 12-May-2016
European Region Turkmenistan Conducted 06-Jun-2016 10-Jun-2016
Region of the Americas United States of America Conducted 23-May-2016 27-May-2016
WHO Health Emergency Dashboard
Yellow Fever

Whooping cough

Oropouche virus disease

Measles

Influenza due to identified avian or animal Influenza virus

Acute gastrointestinal syndrome

Acute Fever and Rash Syndrome

Anthrax, unspecified

Mpox

Cholera

Rubella (German measles)

Influenza due to identified avian or animal influenza virus

Sudan virus disease

Marburg virus disease

Guillain-Barré syndrome

Circulating vaccine-derived poliovirus type 2

Mosquito-borne viral fever, other specified

Armed conflict

Arenaviral haemorrhagic fevers, other

Malaria

Not yet diagnosed

Dengue

Drought

Diphtheria

Crimean-Congo Haemorrhagic Fever

COVID-19

Complex emergency

Civil unrest

Cataclysmic storm

(unknown)

Acute hepatitis E

Adverse effects of a contaminated medical or biological substance, transfused or infused

Botulism

Circulating vaccine-derived poliovirus type 2 (cVDPV2)

A joint external evaluation (JEE) is a voluntary, collaborative, multisectoral process to assess country capacities to prevent, detect and rapidly respond to public health emergencies. The JEE examines capacities across 19 technical areas to establish a baseline assessment, enabling countries to have a greater understanding of their gaps and weaknesses in health security, so they can focus efforts to improve in these areas.

JEE Tutorial
International Health Re…
Joint External Evaluati…
100 Joint External Eval…

Spar

State Party Self-Assessment Annual Reporting Tool (SPAR)

Last updated on 26 Jun 2025
Submitted
Not Submitted
No Information
Level 1
Level 2 & 3
Level 4 & 5
Region Country Year Status Scores
African Region Ghana 2024 Submitted
European Region Finland 2024 Submitted
European Region France 2024 Submitted
African Region Gabon 2024 Submitted
African Region Gambia 2024 Submitted
European Region Georgia 2024 Submitted
European Region Germany 2024 Submitted
Region of the Americas Guatemala 2024 Submitted
African Region Guinea-Bissau 2024 Submitted
African Region Guinea 2024 Submitted
WHO Health Emergency Dashboard
Yellow Fever

Whooping cough

Oropouche virus disease

Measles

Influenza due to identified avian or animal Influenza virus

Acute gastrointestinal syndrome

Acute Fever and Rash Syndrome

Anthrax, unspecified

Mpox

Cholera

Rubella (German measles)

Influenza due to identified avian or animal influenza virus

Sudan virus disease

Marburg virus disease

Guillain-Barré syndrome

Circulating vaccine-derived poliovirus type 2

Mosquito-borne viral fever, other specified

Armed conflict

Arenaviral haemorrhagic fevers, other

Malaria

Not yet diagnosed

Dengue

Drought

Diphtheria

Crimean-Congo Haemorrhagic Fever

COVID-19

Complex emergency

Civil unrest

Cataclysmic storm

(unknown)

Acute hepatitis E

Adverse effects of a contaminated medical or biological substance, transfused or infused

Botulism

Circulating vaccine-derived poliovirus type 2 (cVDPV2)

Under the International Health Regulations(IHR) 2005 all States Parties are required to have or develop and maintain minimum core public health capacities to implement the IHR (2005), and report the status of implementation annually, as stipulated in Article 54 of the Regulations.

The formal submission of data from State Parties to the WHO via the IHR annual reports is very important and will be used as the basis for:

  • reporting to the World Health Assembly, on the status of implementation of these Regulations;
  • informing the GPW 13 indicator on emergency preparedness; and
  • informing UN SDG Goal 3 for indicator 3.d.1 – International Health Regulations (IHR) capacity and health emergency preparedness.

Detailed information on 2019 and previous years up to 2010 of the IHR annual reporting by State Parties are primarily published and available on e-SPAR platform and also at the WHO Global Health Observatory website

How to submit via e-SPAR
International Health Regulation (2005) Monitoring And Evaluation Framework
State Party Self-Assessment Annual Reporting Tool (SPAR)

Detailed information on 2019 and previous years up to 2010 of the IHR annual reporting by State Parties are primarily published and available on e-SPAR platform and also at the WHO Global Health Observatory website

One Health

One Health Operations


What is One Health?

There is no one single definition for “One Health” used by everyone worldwide. In general, the term refers to taking a multisectoral, multi-disciplinary approach and ensuring communication, collaboration, and coordination among all relevant ministries, agencies, stakeholders, sectors, and disciplines, for optimal action.

In the context of the IHR Monitoring and Evaluation Framework, taking a One Health approach means including, from all relevant sectors, the national information, expertise, perspectives, and experience necessary to conduct the assessments, evaluations, reporting and preparedness activities.

National Bridging Workshops

onehealthcontentpic

The WHO International Health Regulations (IHR) (2005) and OIE Performance of Veterinary Services (PVS) assess and support the human and animal health systems, respectively, but coordination across the two sectors remains challenging in many country settings.

The IHR-PVS National Bridging Workshops bring together actors from both sectors and present a structured, guided methodology, allowing participants to collectively identify barriers to synergy and existing gaps in collaboration. Corrective measures are identified to form a road-map to improve the collaboration between the two sectors in the prevention, detection and response to zoonotic disease outbreaks and other health issues at the interface between humans and animals. For more information, please visit the IHR-PVS National Bridging Workshop page.

The WHO International Health Regulations (IHR) (2005) and OIE Performance of Veterinary Services (PVS) assess and support the human and animal health systems, respectively, but coordination across the two sectors remains challenging in many country settings.

The IHR-PVS National Bridging Workshops bring together actors from both sectors and present a structured, guided methodology, allowing participants to collectively identify barriers to synergy and existing gaps in collaboration. Corrective measures are identified to form a road-map to improve the collaboration between the two sectors in the prevention, detection and response to zoonotic disease outbreaks and other health issues at the interface between humans and animals. For more information, please visit the IHR-PVS National Bridging Workshop page.

Taking a Multisectoral, One Health Approach

A Tripartite Guide to Addressing Zoonotic Diseases in Countries

Every day we hear about health challenges at the human-animal-environment interface. Zoonotic diseases such as avian influenza, rabies, Ebola, and Rift Valley fever continue to have major impacts on health, livelihoods, and economies. These health threats cannot be effectively addressed by one sector alone. Multidisciplinary and multisectoral collaboration is needed to tackle them and to reduce their impacts.

As a way to support countries in taking a One Health approach to address zoonotic diseases, the guide: “Taking a Multisectoral, One Health Approach: A Tripartite Guide to Addressing Zoonotic Diseases in Countries” has been jointly developed by the Tripartite organizations (FAO, OIE, and WHO). This Guide, referred to as the Tripartite Zoonotic Guide (TZG) is flexible enough to be used for other health threats at the human-animal-environment interface; for example, food safety and antimicrobial resistance (AMR).

The TZG provides principles, best practices and options to assist countries in achieving sustainable and functional collaboration at the human-animal-environment interface. Examples and lessons learned from countries experiences are also included.
By using the TZG and its associated operational tools (which are currently being developed), countries can build or strengthen their national capacities in:

Tripartite Image

Tripartite Joint Risk Assessment

An interim version of the first Tripartite Operational Tool, for conducting national joint qualitative risk assessments, is currently available to countries wishing to conduct pilots. This Operational Tool is for use by the relevant sectors in countries wishing to conduct a qualitative joint risk assessment for a national priority zoonoses, ongoing zoonotic disease event, or other health threat at the human-animal-environment interface. The final Operational Tool will be available in all six UN languages in 2020. The summary is available here.